Latest updates for Glp1S
Fresh curated links around GLP1s are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- GLP-1s: Still Early In The Growth Story
- Post-bariatric surgery weight loss appears unimpeded by GLP-1 use
- GLP-1s Show Benefit For Kids With Type 2 Diabetes
Post angles to try
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Post-bariatric surgery weight loss appears unimpeded by GLP-1 use
Preoperative GLP-1 receptor agonist use did not impact bariatric surgery outcomes, including weight loss at 1 year, diabetes control and postsurgical complications, according to a...
GLP-1s Show Benefit For Kids With Type 2 Diabetes
FRIDAY, Oct 2, 2026 — A real-world study finds GLP-1 medications helped kids, teens and young adults with type 2 diabetes lose weight, as well as improve their blood pressure and b...
What can GLP-1s do beside treat diabetes and obesity?
GLP-1 agonists go beyond treating metabolic disease. They have shown promise in treating MASH, addiction, sleep apnea, and neurodegeneration. The post What can GLP-1s do beside tre...
What GLP-1s Are Actually Doing For Blood Pressure, From 43K+ Adults
These drugs are quickly proving to go way beyond weight loss.
Are GLP-1s the new statins?
Cardiologists are working the weight-loss drugs into more patient conversations.
Are GLP-1s the New Statins?
The drug is already shaping up as a popular alternative.
As GLP-1s reshape America, questions and new uses emerge
Hailed by some as miracle drugs, GLP-1s have surged in popularity in the past few years. An estimated one out of every eight Americans is now on some version of them and scientists...
GLP-1 Drugs Linked to Fewer Heart Complications and Infections After Surgery, New Study Finds
A new study of more than 2 million surgical patients found that those taking GLP-1 medications had lower odds of serious heart complications and infections after surgery. The findi...
Could GLP-1 drugs be anti-aging medications?
By Brenda Goodman, CNN (CNN) — GLP-1 medications for weight loss and diabetes appear to slow the body’s aging processes, a sign that the blockbuster drugs could ultimately help peo...
Limiting Weight Regain After GLP-1s: Two Strategies Show Promise
WEDNESDAY, Oct. 7, 2026 — What’s the best way to keep the scale from creeping back up after you stop using a GLP-1 medication? A study published today in the journal Obesity Scien...
Could GLP-1 drugs be anti-aging medications?
GLP-1 medications for weight loss and diabetes appear to slow the body’s aging processes, a sign that the blockbuster drugs could ultimately help people live longer.
GLP-1 Receptor Agonists and Diabetic Foot Ulcers
GLP-1 Receptor Agonists Are Associated With Reduced Mortality Following Diabetic Foot Ulcers: A Nationwide Observational Study Jean-Baptiste Bonnet et al Diabetes Care. 2026 Jan 30...
Are GLP-1 users eating out less, or just ordering less?
An estimated 11% of U.S. adults now take a GLP-1 medication for weight loss, up from 3% in 2024, according to Gallup’s 2026 polling. In August 2026, Toast surveyed 850 U.S. adults...
GLP-1s linked to nutritional deficiencies in children
Children prescribed GLP-1 medications for weight loss, prediabetes or type 2 diabetes are at risk for nutritional deficiencies—diagnosed in nearly one in six patients (16.8%) withi...
Yes, GLP-1s Are Changing What Food People Buy — Here's How
And how it compares to people not taking a GLP-1.
GLP-1 Use Surging Among New Mothers
FRIDAY, Oct. 2, 2026 — More women are now being prescribed GLP-1 medications like Ozempic and Zepbound after giving birth. A new study finds GLP-1 use among new mothers jumped from...
One specific clinical group sees huge surge in GLP-1 prescriptions
Real-world findings suggest GLP-1 drugs offer health benefits for young people with diabetes
New research presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, from Sept. 28–Oct. 2 examined the real-world use of GLP-1...
Finally, Some Evidence Employers Can Use to Justify Covering GLP-1s
Finally, Some Evidence Employers Can Use to Justify Covering GLP-1s Anonymous (not verified) Thu, 08/27/2026 - 09:40 pharmagather item url Finally, Some Ev...
GLP-1 medications beyond weight loss: how far could their benefits extend?
What the evidence says about their growing list of established and emerging uses The post GLP-1 medications beyond weight loss: how far could their benefits extend? appeared first...
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.